Immunotherapy Shows Benefit in Prostate Cancer, Dana-Farber Cancer Institute Study
Published: Jul 29, 2010
MedPage Today -- A cellular immunotherapy appears to prolong survival among men with metastatic, castration-resistant prostate cancer, researchers reported.